Navigation Links
WHI Findings Published in JAMA Do Not Affect Clinical Guidance for the Appropriate Use of Hormone Therapy
Date:3/4/2008

Hormone Therapy Remains an Important Option for Women Seeking Relief of

Menopausal Symptoms

COLLEGEVILLE, Pa., March 4 /PRNewswire-FirstCall/ -- Observational follow-up data from the Women's Health Initiative (WHI) study published today in the Journal of the American Medical Association (JAMA) provide little new insight into the appropriate use of hormone therapy when it is prescribed to symptomatic, newly menopausal women. Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), believes that hormone therapy, when used appropriately, remains a good health care choice to relieve moderate to severe menopausal symptoms for millions of women seeking treatment.

"Health care professionals and women should be cautious about drawing generalized conclusions with regard to the benefits and risks of hormone therapy based upon an observational follow-up of the WHI. The WHI was conducted in older women and was designed to assess the risks and benefits of hormone therapy for the prevention of heart disease," says Gary L. Stiles, M.D., Executive Vice President and Chief Medical Officer, Wyeth Pharmaceuticals.

The women who participated in the WHI study were predominantly non-symptomatic and were on average 63 years of age, which is more than a decade past the average onset of menopause. In recent years, reanalysis of WHI findings has repeatedly shown that the risks associated with hormone therapy use in this older study population were not consistently shared across all outcomes by the younger subset of women who are more representative of a newly menopausal, hormone therapy user.

"Selectively releasing information contained in the WHI database, without providing the full context of the data assesse
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
2. Topline Findings from Comparative Analysis of INVEGA(TM) and Quetiapine in Schizophrenia to be Postered at the 20th Annual U.S. Psychiatric and Mental Health Congress
3. Clinical Study Findings Show Safety and Procedure Success for TopSpin IntraVascular MRI Catheter for the Coronary Arteries
4. Arius announces new findings in Trop-2 and CD59 CANCER antibody programs
5. ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells
6. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
7. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
8. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
9. Vasogens Research Published in European Journal of Neuroscience
10. The LANCET Published ENDORSE, the Largest Multinational Study Showing That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE Prophylaxis
11. Newly Published EPA RCRA Method 6800 Supports AIT Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 30, 2014 LayerBio, Inc., an MIT ... its first round of seed financing from friends and ... efforts to develop a novel sustained-release product for ophthalmology. ... investors and their commitment to this important work," said ... is one of many areas in which innovations in ...
(Date:7/29/2014)... (PRWEB) July 30, 2014 “PharmaSphere: ... Equity and Venture Capital Funding” report provides in-depth ... the private equity and venture capital segments of ... are expected to have significant impact on the ... and globally. Furthermore, the report identifies regions of ...
(Date:7/29/2014)... 29, 2014 The advanced optical methods ... that are driving a revolution in the neurosciences were ... journal published by SPIE, the international society for ... with the launch of the BRAIN Initiative in the ... lay out a vision for and provide examples of ...
(Date:7/29/2014)... 29, 2014 Human Longevity, Inc. (HLI), a ... on extending the healthy, high performance human life span, ... Ph.D., an expert in machine learning and machine translation ... HLI from Google where he was Distinguished Research Scientist ... directly to HLI Co-Founder and CEO, J. Craig ...
Breaking Biology Technology:Strategic Trends of Biotech Investment Industry (Private Equity and Venture Capital Funding) in New Report Available at MarketOptimizer.org 2Strategic Trends of Biotech Investment Industry (Private Equity and Venture Capital Funding) in New Report Available at MarketOptimizer.org 3Strategic Trends of Biotech Investment Industry (Private Equity and Venture Capital Funding) in New Report Available at MarketOptimizer.org 4SPIE Launches 'Neurophotonics' Journal with Special Section on BRAIN Initiative 2SPIE Launches 'Neurophotonics' Journal with Special Section on BRAIN Initiative 3SPIE Launches 'Neurophotonics' Journal with Special Section on BRAIN Initiative 4Franz Och, Ph.D., Expert in Machine Learning and Machine Translation, Joins Human Longevity, Inc. as Chief Data Scientist 2Franz Och, Ph.D., Expert in Machine Learning and Machine Translation, Joins Human Longevity, Inc. as Chief Data Scientist 3
... SEATTLE, July 9 Cell Therapeutics, Inc. (CTI),(Nasdaq and ... Providers Act of 2008, as passed by the U.S. ... Senate on July 9, 2008, would,continue the 2007 reimbursement ... a start date of July,1, 2008. In December, Congress ...
... Compensatory Award Will Now Proceed -, MADISON, N.J., July ... motion for judgment as a matter of law on the,punitive ... v.,Wyeth, in the U.S. District Court, Eastern District of Arkansas, ... damages award of,$19,360,000 rendered by the Little Rock jury last ...
... ARBOR, Mich., July 9 Terumo Cardiovascular Systems,(Terumo ... infringement complaint in,Germany against two affiliates of Maquet ... Vertriebs und Service Deutschland GmbH. The complaint,alleges that ... Vessel Harvesting Systems, infringe a patent for which ...
Cached Biology Technology:Congress Extends 2007 Reimbursement Rates for Radioimmunotherapies for 18 Months 2Congress Extends 2007 Reimbursement Rates for Radioimmunotherapies for 18 Months 3Congress Extends 2007 Reimbursement Rates for Radioimmunotherapies for 18 Months 4Wyeth's Motion to Overturn Punitive Damages Award Granted by Arkansas Court 2Wyeth's Motion to Overturn Punitive Damages Award Granted by Arkansas Court 3Terumo Cardiovascular Systems Files Patent Infringement Complaint Against Maquet Affiliates 2
(Date:7/30/2014)... HIV infection could be as simple as inserting a ... University of Washington bioengineers have discovered a potentially faster ... from contracting HIV. Their method spins the drug into ... moisture, releasing higher doses of the drug than possible ... , "This could offer women a potentially more effective, ...
(Date:7/30/2014)... humans figured out how to create colors, nature had ... wings of many different hues, for example. Now scientists ... environmentally friendly way to make colored plastics. Their paper ... of materials rather than dyes, to produce color ... , N. Asger Mortensen, Anders Kristensen and colleagues point ...
(Date:7/30/2014)... been awarded the Scientific Committee on Antarctic Research,s ... , SCAR, an inter-disciplinary international science body, initiates, ... in the Antarctic region, and on the role ... The organisation also provides scientific advice about Antarctica ... the region. , The medal is open internationally ...
Breaking Biology News(10 mins):Dissolvable fabric loaded with medicine might offer faster protection against HIV 2Dissolvable fabric loaded with medicine might offer faster protection against HIV 3
... The Scripps Research Institute has been awarded a $500,000 ... pair of genetic mutations that could lead to a new ... and fatal neurodegenerative disorder. Philip LoGrasso, PhD, a professor ... Scripps Florida, is the principal investigator for the project. ...
... DeKalb, Ill. -- It,s safe to say Northern Illinois ... cats. She keeps two tabbies at her Hampshire, Ill. home. ... anything but cute and cuddly -- the prehistoric saber-tooths. ... of Kansas and fossil hunter John Babiarz -- are editors ...
... warming and its impact on our environment have left ... humans produce. Now, Tel Aviv University researchers are doing ... growing forests in the most unlikely place deep ... such as a local plant species, recycled sewage water ...
Cached Biology News:Scripps Research scientist awarded $500,000 grant to study Parkinson's disease 2Scripps Research scientist awarded $500,000 grant to study Parkinson's disease 3NIU biologist Virginia Naples is helping put new face on ferocious saber-tooth cats 2NIU biologist Virginia Naples is helping put new face on ferocious saber-tooth cats 3Growing something out of nothing 2
RECOMBINANT EQUINE TNF ALPHA Product Type: Recombinant Protein...
... contains 5 ml of DETACHaBEAD 19 ... Dynabeads CD19 (Pan B). B ... B) and released with DETACHaBEAD CD19 ... are suitable for applications such as ...
... Buffers are supplied as 10X concentrated solutions. REact ... each of the REact buffers and one 250 ... of four 1 ml vials of REact 1 ... Buffer four 1 ml vials of REact 3 ...
... The Vybrant Apoptosis Assay Kit #4 ... changes that occur in the permeability of ... of both YO-PRO-1 and propidium iodide nucleic ... the plasma membranes of apoptotic cells and ...
Biology Products: